Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Hyseq presents gene product with potential application to vaccine development

Dec. 28, 1998

Disposition of L-732351, a semisynthetic macrolide immunosuppressant, in animals

Dec. 23, 1998

FDA approves first Lyme disease vaccine

Dec. 22, 1998

Abgenix completes phase II clinical trial in GVHD

Dec. 22, 1998

Abgenix and RCT enter CD45RB antibody collaboration

Dec. 21, 1998

Novartis updates status of immunosuppressive agent

Dec. 17, 1998

SmithKline Beecham and Ribi announce positive HBV phase III trial data

Dec. 16, 1998

MedImmune and BioTransplant initiate two new clinical studies of MEDI-507

Dec. 16, 1998

Vanguard Medica takes on development of imiquimod analogue

Dec. 15, 1998

U.S. patent issues to Alexion, paving the way to improved xenotransplantation technology

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...